A Novel Risk Factor Associated with Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment

Infection Control and Hospital Epidemiology

Volumn 37, Issue 12, 2016, Pages 1418-1425

  Cheng, Vincent C C ^a   Chen, Jonathan H K ^a   So, Simon Y C ^a   Wong, Sally C Y ^a   Chau, Pui Hing ^b   Wong, Lisa M W ^a   Ching, Radley H C ^a   Ng, Modissa M L ^a   Lee, Wan Mui ^a   Hung, Ivan F N ^a   Ho, Pak Leung ^a   Yuen, Kwok Yung ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; DEXLANSOPRAZOLE; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RABEPRAZOLE; ANTIINFECTIVE AGENT;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BROTH DILUTION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CHILD; CITROBACTER FREUNDII; CITROBACTER KOSERI; CONTROLLED STUDY; DRUG USE; ENRICHMENT CULTURE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GASTROINTESTINAL TRACT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; RAOULTELLA; SEX; WOUND; WOUND DRAIN; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; COMPARATIVE STUDY; CROSS INFECTION; ENTEROBACTERIACEAE INFECTION; FECES; HONG KONG; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; HONG KONG; HOSPITALIZATION; HUMANS; INFANT; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RISK FACTORS; YOUNG ADULT;

EID: 85000502330     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2016.202     Document Type: Article

References (39)

1. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012;25:682-707.
2. Villegas MV, Pallares CJ, Escandon-Vargas K, et al. Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing Enterobacteriaceae in seven Latin American countries. PLOS ONE 2016;11:e0154092.
3. Won SY, Munoz-Price LS, Lolans K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemaseproducing Enterobacteriaceae. Clin Infect Dis 2011;53:532-540.
4. Morris D, Boyle F, Morris C, et al. Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother 2012;67:2367-2372.
5. Weterings V, Zhou K, Rossen JW, et al. An outbreak of colistinresistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis 2015;34:1647-1655.
6. Delory T, Seringe E, Antoniotti G, et al. Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management. Am J Infect Control 2015;43:1070-1075.
7. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-855.
8. Hayden MK, Lin MY, Lolans K, et al. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemaseproducing Enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis 2015;60:1153-1161.
9. Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J MedMicrobiol 2013;62:499-513.
10. Ho PL, Li Z, Lai EL, Chiu SS, Cheng VC. Emergence of NDM-1-producing Enterobacteriaceae in China. J Antimicrob Chemother 2012;67:1553-1555.
11. Cheng VC, Chan JF, Wong SC, et al. Proactive infection control measures to prevent nosocomial transmission of carbapenemresistant Enterobacteriaceae in a non-endemic area. Chin Med J (Engl) 2013;126:4504-4509.
12. Rossini A, Di Santo SG, Libori MF, Tiracchia V, Balice MP, Salvia A. Risk factors for carbapenemase-producing Enterobacteriaceae colonization of asymptomatic carriers on admission to an Italian rehabilitation hospital. J Hosp Infect 2016;92:78-81.
13. Cheng VC, Tai JW, Chen JH, et al. Proactive infection control measures to prevent nosocomial transmission of vancomycinresistant enterococci in Hong Kong. J Formos Med Assoc 2014; 113:734-741.
14. Cheng VC, Chen JH, So SY, et al. Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 2015;34:2359-2366.
15. Cheng VC, Chen JH, Poon RW, et al. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene. Eur J Clin Microbiol Infect Dis 2015;34:713-718.
16. Cheng VC, Tai JW, Wong LM, et al. Effect of proactive infection control measures on benchmarked rate of hospital outbreaks: an analysis of public hospitals in Hong Kong over 5 years. Am J Infect Control 2015;43:965-970.
17. Cheng VC, Tai JW, Li WS, et al. Implementation of directly observed patient hand hygiene for hospitalized patients by hand hygiene ambassadors in Hong Kong. Am J Infect Control 2016;44:621-624.
18. Cheng VC, Chau PH, Lee WM, et al. Hand-touch contact assessment of high-touch and mutual-touch surfaces among healthcare workers, patients, and visitors. J Hosp Infect 2015;90:220-225.
19. Ho PL, Cheung YY, Wang Y, et al. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong. Eur J Clin Microbiol Infect Dis 2016;35:379-385.
20. Cheng VC, Chen JH, Wong SC, Ho PL, Yuen KY. Gastrointestinal colonization with multiple New Delhi metallobeta-lactamase-producing Enterobacteriaceae isolates in the same patient: a potential challenge in outbreak investigation. J Hosp Infect 2016;92:108-109.
21. Swaminathan M, Sharma S, Poliansky Blash S, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013;34:809-817.
22. Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control 2014;42:e61-e64.
23. Ben-David D, Masarwa S, Navon-Venezia S, et al. Carbapenemresistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 2011;32:845-853.
24. Yang J, Ye L, Guo L, et al. A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect 2013;19:E509-E515.
25. Zheng R, Zhang Q, Guo Y, et al. Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China. Ann Clin Microbiol Antimicrob 2016;15:10.
26. Cheng VC, Tai JW, Ng ML, et al. Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. Chin Med J (Engl) 2012;125:3450-3457.
27. Guerra B, Fischer J, Helmuth R. An emerging public health problem: acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. Vet Microbiol 2014;171:290-297.
28. Morrison BJ, Rubin JE. Carbapenemase producing bacteria in the food supply escaping detection. PLoS One 2015;10: e0126717.
29. Cheng VC, Wong SC, Ho PL, Yuen KY. Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China. Emerg Microbes Infect 2015;4:e8.
30. Cheng VC, Li IW, Wu AK, et al. Effect of antibiotics on the bacterial load of meticillin-resistant Staphylococcus aureus colonisation in anterior nares. J Hosp Infect 2008;70:27-34.
31. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012;67:2976-2981.
32. Gagliotti C, Giordani S, Ciccarese V, et al. Risk factors for colonization with carbapenemase-producing Klebsiella pneumoniae in hospital: a matched case-control study. Am J Infect Control 2014;42:1006-1008.
33. Lubbert C, Lippmann N, Busch T, et al. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany. AmJ Infect Control 2014;42:376-380.
34. Jackson MA, Goodrich JK, Maxan ME, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 2016;65:749-756.
35. Dang TT, Majumdar SR, Marrie TJ, Eurich DT. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients. Drugs Aging 2015;32:13-19.
36. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012;107:1001-1010.
37. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012;107:1011-1019.
38. Corleto VD, Festa S, Di Giulio E, Annibale B. Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes 2014;21:3-8.
39. Fung IC, Cairncross S. How often do you wash your hands? A review of studies of hand-washing practices in the community during and after the SARS outbreak in 2003. Int J Environ Health Res 2007;17:161-183.